Lightpoint Medical raises £5m
Medical technology firm Lightpoint Medical has raised ТЃ5m from a group of investors.
Investors in the round included Cambridge Capital Group, Venture Founders, Coutts Investment Club, Envestors, Fund Twenty8, SyndicateRoom and Oxford Technology.
The funding will be used to commercialise its latest product, a robotic laparoscopic probe, and support the growth of existing products.
It also received a grant for £3m from EU-backed programme Horizon 2020 SME Instrument, and Innovate UK.
Company
Lightpoint was established in 2012 and is based in Chesham, near London. It produces technology that allows cancer to be detected in real time during surgery, with the aim of improving tissue sparing and clinical outcomes. The technology is based on administering patients a cancer-targeted imaging drug and then detecting it live during surgery.
People
Cambridge Capital Group – Stuart McDougall (managing director).
VentureFounders – James Codling (managing director).
Fund Twenty8 – James Sore (fund manager).
Lightpoint Medical – David Tuch (CEO).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds









